Stereotaxis

$2.60 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Stereotaxis

Stereotaxis, Inc. is a United States-based healthcare technology company. The Company is engaged in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease. The Company also provides information management solutions for the interventional lab. The Stereotaxis platform helps physicians to provide patient care with robotic precision and enhanced integration of procedural information. The Company’s Epoch solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The Niobe ES remote magnetic navigation system includes the Navigant software user interface and the QuikCAS catheter advancement system. The Vdrive robotic navigation system with Niobe ES magnetic navigation system provides navigation and stability for diagnostic and ablation devices.

Stock Analysis

last close $2.62
1-mo return 19.1%
3-mo return 46.4%
avg daily vol. 287.61T
52-week high 7.32
52-week low 1.72
market cap. $169M
forward pe -
annual div. -
roe -51.8%
ltg forecast -
dividend yield -
annual rev. $31M
inst own. 50%
baraka

Subscribe now for daily local and international financial news

Subscribe